Posted by Al Doig | Under Biopharmaceuticals, bioTRAK data, Continuous Processing, Cost of Goods (COGS), Disruptive technologies, Manufacturing technology
Monday Jun 27, 2016
Posted by Al Doig | Under Biopharmaceuticals, Conference announcement, Process development
Monday Jun 20, 2016
Thomas C. Ransohoff, M.S., Vice President and Principal Consultant at BPTC, gave a presentation entitled “Opportunities for Continuous Manufacturing in Biopharmaceutical Production” at the World BioPharm Forum 2016: Progress in Continuous Biomanufacturing, on June 28, 2016 held at Robinson College, Cambridge, UK. Tom’s presentation focused the potential benefits of continuous manufacturing in the production of bio/pharmaceuticals as well as the challenges in implementing these and other new technologies in the production of biopharmaceuticals. His presentation presented current trends in supply and demand for biopharmaceutical manufacturing capacity based on information from BPTC’s bioTRAK® database. Using this information, an analysis the application areas that represent the most attractive near-term opportunities for implementing continuous manufacturing in our industry were presented. Challenges specific to these application areas were also reviewed. Follow the link above for a pdf of Tom’s presentation.
Posted by Al Doig | Under Antibody drug conjugates, Biopharmaceuticals, Breakthrough therapy, Cell/gene therapies, Conference announcement, Disruptive technologies, Manufacturing technology, Process development
Friday May 20, 2016
Title: CMC Strategy Forum
Location: Gaithersburg, MD
Link out: Click here
Description: Joseph Siemiatkoski, Consultant at BPTC will be attending the CMC Strategy Forums “Emerging Strategies in Drug Product Comparability and Process Validation” and “Change Happens: Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management” during the CaSSS CMC Strategy Forum -Summer 2016 Symposium to be held at the Gaithersburg Marriott Washingtonian Center from July 18-21, 2016.
Start Date: 2016-07-18
End Date: 2016-07-21
Posted by Al Doig | Under Biopharmaceuticals, Biosimilars, bioTRAK, Breakthrough therapy, Cell line development, Cell/gene therapies, Conference announcement, Disruptive technologies, Early-stage development, Manufacturing capacity, Monoclonal antibodies, Process development, Purification, Regulatory, Vaccines
Wednesday May 11, 2016
Patricia Seymour, Senior Consultant, BioProcess Technology Consultants, Inc. will lead a panel discussion entitled, Emerging Bio-Therapies and Their Manufacturing Challenges at the BioProcess Intl, BioProcess Theater at BIO 2016 June 6-9 in San Francisco, CA. Panel experts will focus on the emerging therapies using cell and gene therapy, drug conjugates, bispecific antibodies and others, and the unique manufacturing challenges these therapies present. The panel will cover:
- Process development and manufacturability of these therapies
- Access to manufacturing facilities for these therapies – outsource or build
- 20/20 – how prevalent will these therapies be by 2020 and beyond, and will industry be able to meet the demand
Please stop at the BPTC booth #6267 while at BIO 2016.
Posted by Al Doig | Under Continuous Processing, Disruptive technologies, Manufacturing technology, Purification
Friday May 6, 2016
Title: BIO International Convention 2016
Location: San Francisco, CA.
Description: Join BPTC at the annual BIO International Convention 2016 in beautiful San Francisco, CA from June 6-9, 2016 to exchange ideas and insights on biotech’s most relevant and timely topics with the industry’s thought-leaders. Patti Seymour (pseymourbptccom) , Senior Consultant and supply chain expert, will be making a presentation entitled, “The Changing Landscape for Biomanufacturing: Product Strategies, Market Environment, and Biomanufacturing Dynamics” on Monday, June 6th at 1:00 p.m. in Room West 3008. While you are at BIO, stop by booth #6267 to meet with our subject matter experts and explore how we can support the technical, strategic, and regulatory aspects of your biopharmaceutical development programs.
BPTC’s Tom Ransohoff, Vice President and Principal Consultant, will be presenting at the World Biopharm Forum
2016: Progress in Continuous Biomanufacturing to be held in
Cambridge, U.K. on Jun 27-28, 2016. Mr. Ransohoff’s presentation will
be titled “Opportunities for Continuous Manufacturing in the
Production of Biopharmaceuticals” and will review areas where
continuous manufacturing may be deployed as the approach continues
to make inroads in the biopharmaceutical field.